Drugstore Co., Ltd. (YSB) filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on March 6, 2024, reporting the company's stock changes as of February 29, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH, REMAINING AT 20,000,000,000 SHARES OF ORDINARY SHARES WITH A FACE VALUE OF $0.000000025 PER SHARE AND A TOTAL STATUTORY/REGISTERED SHARE CAPITAL OF $50,000. Under the 2023 Share Incentive Plan, the company granted 10,552,500 share options in February with a small number of stock options having lapsed. As of the end of this month, the Company still has 14,214,500 share options available for future issuance under the 2023 Share Incentive Plan. The Plan was adopted on June 12, 2023 and effective...Show More

Drugstore Co., Ltd. (YSB) filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on March 6, 2024, reporting the company's stock changes as of February 29, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH, REMAINING AT 20,000,000,000 SHARES OF ORDINARY SHARES WITH A FACE VALUE OF $0.000000025 PER SHARE AND A TOTAL STATUTORY/REGISTERED SHARE CAPITAL OF $50,000. Under the 2023 Share Incentive Plan, the company granted 10,552,500 share options in February with a small number of stock options having lapsed. As of the end of this month, the Company still has 14,214,500 share options available for future issuance under the 2023 Share Incentive Plan. The Plan was adopted on June 12, 2023 and effective on June 28 of the same year. The Plan's authorization limit is 63,235,005 shares, i.e. up to 10% of the shares issued on the date of listing. The report does not mention changes in other types of securities and confirms that all securities issues have been formally authorized by the Board of Directors.